Literature DB >> 6627597

Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.

A T McGown, T H Ward, B W Fox.   

Abstract

The intracellular accumulation of daunorubicin as determined by flow cytometry correlates well with that as determined by extraction of the drug from cell homogenates. Two P388 mouse leukaemia cell lines showing differential sensitivity to the drug have been used to investigate the transport changes associated with resistance. Resistance to daunorubicin in these cell lines occurs through an alteration in the intracellular accumulation of the drug, resulting from the increased efflux of the anthracycline from the resistant cells. The effect of temperature, drug concentration, pH, and metabolic inhibitors on this process have been investigated. Uptake by a carrier-mediated process of the un-ionised form of the drug (pK = 8.25), coupled with an energy-dependent efflux process, is proposed as the mechanism of cellular accumulation in the case of the resistant cell line.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6627597     DOI: 10.1007/bf00254258

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  16 in total

1.  Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation.

Authors:  N R Bachur; S L Gordon; M V Gee
Journal:  Mol Pharmacol       Date:  1977-09       Impact factor: 4.436

2.  The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

Authors:  J M KISSANE; E ROBINS
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

3.  Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.

Authors:  K Dano
Journal:  Biochim Biophys Acta       Date:  1973-10-25

4.  Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.

Authors:  J J Wang; D S Chervinsky; J M Rosen
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

5.  The anticancer agent adriamycin can be actively cytotoxic without entering cells.

Authors:  T R Triton; G Yee
Journal:  Science       Date:  1982-07-16       Impact factor: 47.728

6.  Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.

Authors:  G Noel; C Peterson; A Trouet; P Tulkens
Journal:  Eur J Cancer       Date:  1978-04       Impact factor: 9.162

7.  A fluorescence polarization flow cytometer.

Authors:  J P Keene; B W Hodgson
Journal:  Cytometry       Date:  1980-09

8.  Measurements of daunorubicin uptake of Yoshida sarcoma cells in culture using flow cytofluorimetry.

Authors:  A Garner; B W Fox
Journal:  Chem Biol Interact       Date:  1981-08       Impact factor: 5.192

9.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

10.  Digitized video fluorescence microscopy studies of adriamycin interaction with single P388 leukemic cells.

Authors:  S Yanovich; R N Taub
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

View more
  8 in total

1.  Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines.

Authors:  A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting.

Authors:  G C Rice; G M Hahn
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.

Authors:  K Nooter; R Oostrum; R Jonker; H van Dekken; W Stokdijk; G van den Engh
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy.

Authors:  A T McGown; D Murphy; D Crowther; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Pre-clinical studies of a novel anti-mitotic agent, amphethinile.

Authors:  A T McGown; C Ewen; D B Smith; B W Fox
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

6.  Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.

Authors:  A McGown; D G Poppitt; B W Fox
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

7.  Twenty-eighth annual meeting of the British Association for Cancer Research (in conjunction with the second annual meeting of the Association of Cancer Physicians). April 6-8, 1987, Newcastle-upon-Tyne, UK. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

8.  Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.

Authors:  J Prendiville; A T McGown; A Gescher; A J Dickson; C Courage; G R Pettit; D Crowther; B W Fox
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.